GLP-1 is a compelling breakthrough in our control landscape . Originally designed to treat diabetes , this class of drugs have demonstrated noteworthy ability to encourage slimming and improve metabolic fitness. Experts are now studying the impact in treating obesity in patients who don’t have the condition . GLP-3 Agonist RT: A Horizon of